miR-650 Promotes the Metastasis and Epithelial –Mesenchymal Transition of Hepatocellular Carcinoma by Directly Inhibiting LATS2 Expression
Conclusion: In conclusion, the miR-650/LATS2 pathway may serve as a novel prognostic biomarker and an attractive therapeutic target for HCC patients.Cell Physiol Biochem 2018;51:1179 –1192
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research
More News: Biochemistry | Cancer & Oncology | Carcinoma | Cytology | Epithelial Cancer | Genetics | Hepatocellular Carcinoma | Liver Cancer | Physiology | Study